Lincomycin NDC 72485-115

NDC codes

FDA NDC Directory

Product NDC (as listed)72485-115Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72485-0115Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72485-115-10	72485011510	10 VIAL, MULTI-DOSE in 1 CARTON (72485-115-10) / 10 mL in 1 VIAL, MULTI-DOSE (72485-115-01)Marketed from May 5, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lincomycin
Generic name (nonproprietary): lincomycin
Active ingredients: Lincomycin hydrochloride — 3000 mg/10mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Armas Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215082
Marketing start: May 5, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 72485-115_2b18b782-a0a7-4072-b573-e66de82eae06SPL ID 2b18b782-a0a7-4072-b573-e66de82eae06SPL set ID ebabccf4-f082-4fc0-9223-f4826dc89b13RxCUI 239212UNII M6T05Z2B68UPC 0372485115013

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472485011510 followed by a unit qualifier and the quantity

Package 72485-0115-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 18, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lincomycin injection is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of CDAD, as described in the BOXED WARNING , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. Indicated surgical procedures should be performed in conjunction with antibacterial therapy. Lincomycin injection may be administered concomitantly with other antimicrobial agents wh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215082

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215082
Product	Strength	Form · route	Labeler	Product NDC
Lincomycin	Lincomycin hydrochloride 600 mg/2mL	Injection, SolutionIntramuscular, Intravenous	Armas Pharmaceuticals Inc.	72485-114
Lincomycin	Lincomycin hydrochloride 300 mg/mL	Injection, SolutionIntramuscular, Intravenous	Micro Labs Limited	42571-374